Atherosclerosis
Volume 203, Issue 2 , Pages 494-502 , April 2009

Ethnic and sex differences in circulating endotoxin levels: A novel marker of atherosclerotic and cardiovascular risk in a British multi-ethnic population

  • Michelle A. Miller

      Affiliations

    • Clinical Sciences Research Institute, Warwick Medical School, Coventry, UK
    • Corresponding Author InformationCorresponding author at: Clinical Sciences Research Institute, Clinical Sciences Building-UHCW Campus, Warwick Medical School, Clifford Bridge Road, Coventry CV2 2DX, UK. Tel.: +44 24 7696 8666; fax: +44 24 7696 8660.
    • ,
  • Philip G. McTernan

      Affiliations

    • Clinical Sciences Research Institute, Warwick Medical School, Coventry, UK
    • ,
  • Alison L. Harte

      Affiliations

    • Clinical Sciences Research Institute, Warwick Medical School, Coventry, UK
    • ,
  • Nancy F. da Silva

      Affiliations

    • Clinical Sciences Research Institute, Warwick Medical School, Coventry, UK
    • ,
  • Pasquale Strazzullo

      Affiliations

    • Department of Clinical & Experimental Medicine, Federico II University, Naples, Italy
    • ,
  • K. George M.M. Alberti

      Affiliations

    • Department of Endocrinology and Metabolism, St Mary's Hospital, Imperial College, London, UK
    • ,
  • Sudhesh Kumar

      Affiliations

    • Clinical Sciences Research Institute, Warwick Medical School, Coventry, UK
    • ,
  • Francesco P. Cappuccio

      Affiliations

    • Clinical Sciences Research Institute, Warwick Medical School, Coventry, UK

Received 14 March 2008 ,Revised 13 June 2008 ,Accepted 13 June 2008.

References 

  1. Balarajan R. Ethnicity and variations in the nation's health. Health Trends 1995–96;27:114–119.
  2. Cooper RS, Ghali JK. Coronary heart disease: black–white differences. Cardiovasc Clin. 1991;21:205–225
  3. Cappuccio FP. Ethnicity and cardiovascular risk: variations in people of African ancestry and South Asian origin. J Hum Hypertens. 1997;11:571–576
  4. Cappuccio FP, Cook DG, Atkinson RW, Strazzullo P. Prevalence, detection, and management of cardiovascular risk factors in different ethnic groups in south London. Heart. 1997;78:555–563
  5. Cappuccio FP, Cook DG, Atkinson RW, Wicks PD. The Wandsworth Heart & Stroke Study. A population-based survey of cardiovascular risk factors in different ethnic groups. Methods and baseline findings. Nutr Metab Cacrdiovasc Dis. 1998;8:371–385
  6. Miller MA, Cappuccio FP. Ethnicity and inflammatory pathways—implications for vascular disease. Vasc Risk Therap Interv Curr Med Chem. 2007;14(13):1409–1425Review
  7. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836–843
  8. Koh KK, Han SH, Quon MJ. Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions. J Am Coll Cardiol. 2005;46:1978–1985
  9. Hwang SJ, Ballantyne CM, Sharrett AR, et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 1997;96:4219–4225
  10. Miller MA, Sagnella GA, Kerry SM, Strazzullo P, Cook DG, Cappuccio FP. Ethnic differences in circulating soluble adhesion molecules. The Wandsworth heart and stroke study. Clin Sci (Lond). 2003;104:591–598
  11. Miller MA, Cappuccio FP. Cellular adhesion molecules and their relationship with measures of obesity and metabolic syndrome in a multiethnic population. Int J Obes. 2006;30:1176–1182
  12. Medzhitov R, Janeway CA. An ancient system of host defense. Curr Opin Immunol. 1998;10:12–15
  13. Kaisho T, Akira S. Toll-like receptors as adjuvant receptors (68). Biochim Biophys Acta. 2002;1589:1–13
  14. Muzio M, Polentarutti N, Bosisio D, Manoj Kumar PP, Mantovani A. Toll-like receptor family and signalling pathway. Biochem Soc Trans. 2000;28:563–566
  15. Creely SJ, McTernan PG, Kusminski CM, et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab. 2007;292:E740–E747
  16. Barcia AM, Harris HW. Triglyceride-rich lipoproteins as agents of innate immunity. Clin Infect Dis. 2005;41(Suppl. 7):S498–S503
  17. Levels JH, Marquart JA, Abraham PR, et al. Lipopolysaccharide is transferred from high-density to low-density lipoproteins by lipopolysaccharide-binding protein and phospholipid transfer protein. Infect Immun. 2005;73:2321–2326
  18. Erridge C, Attina T, Spickett CM, Webb DJ. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr. 2007;86(5):1286–1292
  19. Wiedermann CJ, Kiechl S, Dunzendorfer S, et al. Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. J Am Coll Cardiol. 1999;34(7):1975–1981
  20. Cappuccio FP, Oakeshott P, Strazzullo P, Kerry SM. Application of Framingham risk estimates to ethnic minorities in United Kingdom and implications for primary prevention of heart disease in general practice: cross sectional population based study. BMJ. 2002 Nov;325:1271–1274
  21. Walrand S, Guillet C, Boirie Y, Vasson MP. In vivo evidences that insulin regulates human polymorphonuclear neutrophil functions. J Leukoc Biol. 2004;76:1104–1110
  22. Cornell RP. Mechanisms of acute hyperinsulinemia after Kupffer cell phagocytosis. Am J Physiol. 1980;238:E276–E283
  23. Cornell RP. Endogenous gut-derived bacterial endotoxin tonically primes pancreatic secretion of insulin in normal rats. Diabetes. 1985;34:1253–1259
  24. Rovers C, Netea MG, de Bont N, et al. LPS-induced cytokine production and expression of beta2-integrins and CD14 by peripheral blood mononuclear cells of patients with homozygous familial hypercholesterolemia. Atherosclerosis. 1998;141:99–105
  25. Wurfel MM, Hailman E, Wright SD. Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein. J Exp Med. 1995;181:1743–1754
  26. Parker TS, Levine DM, Chang JC, Laxer J, Coffin CC, Rubin AL. Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood. Infect Immun. 1995;63:253–258
  27. Fernandez-Real JM, Broch M, Richart C, Vendrell J, Lopez-Bermejo A, Ricart W. CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity. J Clin Endocrinol Metab. 2003;88:1780–1784
  28. Harris HW, Grunfeld C, Feingold KR, et al. Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin Invest. 1993;91:1028–1034
  29. Walker FR, Owens J, Ali S, Hodgson DM. Individual differences in glucose homeostasis: do our early life interactions with bacteria matter?. Brain Behav Immun. 2006;20:401–409
  30. Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56(7):1761–1772

PII: S0021-9150(08)00445-0

doi: 10.1016/j.atherosclerosis.2008.06.018

Atherosclerosis
Volume 203, Issue 2 , Pages 494-502 , April 2009

Article Tools

* Image Usage & Resolution